These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15569336

  • 21. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.
    Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K.
    Am J Kidney Dis; 2008 Oct; 52(4):727-36. PubMed ID: 18760517
    [Abstract] [Full Text] [Related]

  • 22. Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid.
    Bonforte G, Grillo P, Zerbi S, Surian M.
    Blood Purif; 2002 Oct; 20(4):357-63. PubMed ID: 12169845
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hospitalization risks related to vascular access type among incident US hemodialysis patients.
    Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, Bradbury BD.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3659-66. PubMed ID: 21372255
    [Abstract] [Full Text] [Related]

  • 31. Factors affecting anemia management in hemodialysis patients: a single-center experience.
    Spiegel DM, Gitlin M, Mayne T.
    Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risk factors of vascular access failure in patients on hemodialysis.
    Gheith OA, Kamal MM.
    Iran J Kidney Dis; 2008 Oct; 2(4):201-7. PubMed ID: 19377238
    [Abstract] [Full Text] [Related]

  • 34. rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients.
    Erkmen Uyar M, Toprak SK, Saglam H, Tutal E, Bay M, Ilhan O, Bal Z, Sezer S.
    ScientificWorldJournal; 2013 Oct; 2013():792698. PubMed ID: 24198729
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?
    Kausz AT, Solid C, Pereira BJ, Collins AJ, St Peter W.
    Am J Kidney Dis; 2005 Jan; 45(1):136-47. PubMed ID: 15696453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.